>
You are Emitting RF. Devices Like Signal-Trace Tracks Your Signature
'British hero' pulled Flydubai hijack jet out of 'death plunge' after 'jihadist*
Kennedy Touts AI Over Doctors At Industry-Backed Summit
Signs Of Fresh Houthi Attack On Saudi Aramco Facilities
Elon Musk's Next-Gen Motor Destroy Entire EV Industry
China's disputed satellite refueling heralds new space war era
BYD Will Put Solid-State Batteries In An EV Next Year: Executive
FDA-cleared exoskeleton puts spinal-cord patients back on their feet
Your Robotic Vacuum Is Watching You -- Could It Someday Testify Against You in Court?
Why Unigrid's Sodium-Ion Batteries Are the Game-Changer for Off-Grid Energy Storage
This Battery On Wheels Makes Any Diesel Truck Electric In 5 Minutes
Mass-Production of AI Infrastructure – Speed Up by 10X
3D-printed Martian mud homes look critical for life beyond Earth
Inside The Texas Factory Racing To Break China's Grip On EV Magnets

The ability to engineer particles that can enter a human body and transport a drug directly to a targeted cell is revolutionizing how medicine is delivered. A team of researchers from the University of Illinois has now created a new nanoparticle therapy that can target and destroy cancer stem cells to stop the disease returning.
The fear of relapse is one that constantly haunts cancer patients after any initial treatment has moved the disease into remission, but understanding how and why cancer returns eluded scientists for many years. In the mid-1990s, researcher John Dick first identified cancer stem cells, upending the field of cancer research and pointing to an entirely new area of study for scientists.
The discovery was that some cancers can be generated by these cancer stem cells (CSCs), and many existing treatments, while effective in destroying fast-growing cancer cells, completely miss these CSCs.